2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Hyperoxaluria: new trials by email Literature Review of Hyperoxaluria trials Research Report on Hyperoxaluria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria Reloxaliase, Placebo - Enteric Hyperoxaluria | Phase 3 | Terminated | Allena Pharmaceuticals | 92 | 2019-08-26 | 2022-06-10 |
| An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria Oxabact OC5 - Oxalobacter formigenes Strain HC-1 - Hyperoxaluria, Primary | Phase 3 | Terminated | OxThera | 22 | 2019-03-14 | 2021-12-08 |
Hyperoxaluria, Primary (1) · Kidney Calculi (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Calculi (1) · Carbohydrate Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nephrolithiasis (1) · Nutritional and Metabolic Diseases (1)
oxalate decarboxylase (1) · reloxaliase (1)
Allena Pharmaceuticals (1) · OxThera (1)
Belgium (2) · Germany (2) · Spain (2) · United Kingdom (2) · United States (2) · Austria (1) · Brazil (1) · Canada (1) · Croatia (1) · France (1) · Italy (1) · Mexico (1) · Portugal (1) · Romania (1) · Russia (1)
David Clark, MD (1) · Gesa Schalk, MD (1)
2018 (1)